Rocket Pharmaceuticals, Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€2.19M - Gross profit
-€2.19M - SG&A expenses
€91.25M - R&D expenses
€136.36M - EBITDA
-€211.16M - D&A
€8.89M - EBIT
-€230.60M - Interest expenses
€1.63M - EBT
-€221.68M - Tax expenses
€0.00 - Net income
-€221.68M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€2.53M - Changes in working capital
€2.21M - Operating cash flow
-€175.58M - Capex
€1.99M - Other investing cash flow
€0.00 - Net investing cash flow
€12.73M - Total cash dividends paid
€0.00 - Issuance of common stock
€157.87M - Debt repayment
€11.20K - Other financing cash flow
€140.43K - Net financing cash flow
€157.87M - Foreign exchange effects
€0.00 - Net change in cash
-€4.98M - Cash at end of period
€29.45M - Free cash flow
-€173.59M
Balance sheet
- Cash and cash equivalents
€28.28M - Cash and short-term investments
€233.91M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€4.88M - Total current assets
€238.78M - Property, plant & equipment
€66.89M - Goodwill
€33.73M - Intangible assets
€21.67M - Long-term investments
€0.00 - Other non-current assets
€1.62M - Total non-current assets
€123.91M - Total assets
€362.69M - Accounts payable
€0.00 - Short-term debt
€2.49M - Other current liabilities
€34.90M - Total current liabilities
€37.39M - Long-term debt
€19.22M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€914.10K - Total non-current liabilities
€20.13M - Total liabilities
€57.52M - Common stock
€929.61K - Retained earnings
-€1.16B - Other equity
-€92.19K - Total equity
€305.17M - Total liabilities and shareholders' equity
€362.69M
Company information
- Market capitalization
€232.50M - Employees
299 - Enterprise Value
€301.99M
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-72.6% Much worse than peer group: 79.0% - ROA
-
-61.1% Better than peer group: -68.6% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-76.4% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€741.39K